MET
MetLife, Inc.$70.60
Buy
Target $92.14
Report: Mar 11, 2026Financial Services • Insurance - Life • Mature CompounderSnapshot
Decision-first overview with recommendation, valuation anchor, and current setup.
Company Overview
Research Snapshot
Price History
Pelican View
Current$70.60+30.5%
Rec: BuyConviction: Medium
Entry Target
$70.60
(0% above current)
Fair Value
$92.14
(31% above current)
Stop Loss
$65.20
(8% below current)
Position Size
Half
Time Horizon
Long-Term
Key Metrics
Live Snapshot
Market Data
52 Week High$83.85
52 Week Low$65.21
Avg. 3 Month Volume3.96M
Efficiency
LTM Gross Margin24.0%
LTM EBITDA Margin7.0%
LTM EBIT Margin6.0%
LTM Operating Margin6.0%
LTM ROA0.4%
LTM ROE11.3%
LTM ROIC0.7%
LTM ROCE0.7%
Capital Structure
Market Cap (MM)$46.1B
Enterprise Value (MM)$44.6B
Shares Outstanding652.05M
Total Debt (MM)$20.54B
Cash & Equivalents (MM)$22.03B
LTM Net Debt (MM)$-1.50B
LTM Net Debt/EBITDA-0.3x
Growth
TTM Rev. Growth8.6%
Last 3-Yr Rev. CAGR3.3%
Last 3-Yr EBITDA CAGR15.3%
Last 3-Yr EPS CAGR17.3%
Valuation
Street Target Price$96.83
LTM EV/Revenue0.6x
LTM EV/Gross Profit2.4x
LTM EV/EBIT9.6x
LTM EV/EBITDA8.3x
LTM P/E14.5x
LTM EV/FCF2.6x
LTM P/FCF2.7x
LTM P/TB0.1x
LTM P/B1.6x
Dividend Yield3.2%
Payout Ratio47.9%
Executive SummarySituation: Current price is $70.6 versus fair value $92.14 (30.5% expected return), and valuation confidence is stable. Debate: Bull case depends on PineBridge integration delivers MIM $240-280M earnings and +30% revenues, validating asset management convergence and countering RIS spread fears (99bps) with diversified cash flows. Bear case centers on Moat erosion via destructive pricing permanently impairs pricing power, compressing gross margin further below peer 45.1% median as rivals preserve 13.3% op margins. Conclusion: Recommendation is Buy with Half sizing and Long-Term horizon.
Bull Case
Abundant FCF $17,092M (37.1% yield) funds $4.4B returns FY2025; New Frontier delivers PRT record $14B, Asia +18%, MIM +30% revenues; institutional net buy +7.1M shares Q4 2025 (Vanguard +12.1%); analyst targets avg $97.50 (+38%).
Bear Case
Gross margin 24.0% trails peers 45.1% by 21.1pts signaling moat erosion; ROIC 0.7% <9.5% WACC; guidance hit 20% revenue/0% EPS; stock -31.6% vs S&P YTD; short interest 2.0% rising.
Key Catalysts
Mid-Term (6-18 months)Impact: High
PineBridge integration delivers MIM $240-280M earnings and +30% revenues, validating asset management convergence and countering RIS spread...
Near-Term (0-6 months)Impact: Moderate
Expense ratio hits 12.1% target (PineBridge-adjusted) via AI/MetIQ, offsetting disability claims and restoring op margin toward 7.9% FY2024...
Long-Term (18+ months)Impact: Moderate
Q4 2025 adjusted EPS $8.89 (+10% YoY) and $14B PRT record amid bearish technicals (RSI 33.83) create timely entry for compounding thesis.
Primary Risks
Concern: High
Moat erosion via destructive pricing permanently impairs pricing power, compressing gross margin further below peer 45.1% median as rivals p...
Concern: Medium
Japan ESR transition or yen volatility spikes surrenders, eroding Asia persistency and sales (+18% YoY at risk).
Concern: Medium
Stewardship strong: LTI 70% performance shares (3Y TSR vs peers, adjusted ROE vs plan); board skills cover insurance (Mumenthaler ex-Swiss R...
Recent Activity
2026-02-27SEC Filing (8-K)
-5.10%MetLife issued $1 billion in 5.850% Fixed-to-FixedReset Rate Subordinated Debentures due 2056
2025-04-03Press Release
-7.98%Metlife Foundation Commits $5 Million To Expand Its Community Impact Grant Program
2024-10-31SEC Filing (8-K)
-5.72%MetLife reports Q3 2024 earnings with 33% book value increase
2024-08-02SEC Filing (SC 13D/A)
-6.89%MetLife Board amends Schedule 13D to report Trust holdings
2024-02-01SEC Filing (8-K)
-5.73%MetLife announces full year and fourth quarter 2023 results with net income of $1.4 billion and adjusted earnings of $5.5 billion
Valuation Table
9.8/10Decision Grade
Scenario Range
$65
Bear
$90
Base
$108
Bull
$71